Phreesia (NYSE:PHR) Given New $25.00 Price Target at Robert W. Baird

Phreesia (NYSE:PHR) had its price objective trimmed by Robert W. Baird from $31.00 to $25.00 in a research report report published on Wednesday, MarketBeat reports. The brokerage currently has an outperform rating on the stock.

Other research analysts have also recently issued reports about the stock. DA Davidson upped their price objective on shares of Phreesia from $33.00 to $35.00 and gave the stock a “buy” rating in a research report on Tuesday, December 2nd. Needham & Company LLC restated a “buy” rating and set a $35.00 price objective on shares of Phreesia in a research report on Monday. Stephens reaffirmed an “overweight” rating and set a $32.00 price objective on shares of Phreesia in a report on Wednesday, September 3rd. KeyCorp reduced their target price on Phreesia from $35.00 to $32.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 8th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Phreesia in a research note on Friday, October 31st. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Phreesia presently has a consensus rating of “Moderate Buy” and an average target price of $31.13.

Phreesia Stock Up 2.5%

PHR opened at $15.82 on Wednesday. The firm has a market capitalization of $947.48 million, a P/E ratio of -158.13 and a beta of 0.64. Phreesia has a one year low of $15.41 and a one year high of $32.76. The company has a fifty day moving average price of $21.73 and a 200-day moving average price of $25.12. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.12 and a quick ratio of 2.12.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Monday, December 8th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.11. The company had revenue of $120.33 million during the quarter, compared to analyst estimates of $119.98 million. Phreesia had a negative return on equity of 1.36% and a negative net margin of 1.16%.The firm’s quarterly revenue was up 12.7% on a year-over-year basis. During the same quarter last year, the company earned ($0.25) earnings per share. Equities research analysts expect that Phreesia will post -1.1 earnings per share for the current fiscal year.

Insider Transactions at Phreesia

In other Phreesia news, CFO Balaji Gandhi sold 4,183 shares of the stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $23.28, for a total transaction of $97,380.24. Following the completion of the sale, the chief financial officer owned 99,125 shares of the company’s stock, valued at $2,307,630. This represents a 4.05% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider David Linetsky sold 2,059 shares of the firm’s stock in a transaction on Friday, October 17th. The stock was sold at an average price of $22.36, for a total transaction of $46,039.24. Following the completion of the sale, the insider directly owned 171,829 shares in the company, valued at approximately $3,842,096.44. This trade represents a 1.18% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 26,174 shares of company stock valued at $603,835. Insiders own 5.50% of the company’s stock.

Institutional Trading of Phreesia

Several large investors have recently modified their holdings of PHR. Cubist Systematic Strategies LLC purchased a new position in shares of Phreesia during the first quarter valued at about $774,000. Farther Finance Advisors LLC lifted its holdings in Phreesia by 9,375.0% in the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock worth $86,000 after buying an additional 3,000 shares during the period. Arcadia Investment Management Corp MI boosted its position in Phreesia by 22.3% during the 2nd quarter. Arcadia Investment Management Corp MI now owns 113,470 shares of the company’s stock valued at $3,229,000 after acquiring an additional 20,700 shares in the last quarter. Acadian Asset Management LLC grew its holdings in shares of Phreesia by 61.6% during the 2nd quarter. Acadian Asset Management LLC now owns 364,194 shares of the company’s stock worth $10,357,000 after acquiring an additional 138,877 shares during the period. Finally, Deutsche Bank AG raised its position in shares of Phreesia by 30.6% in the 1st quarter. Deutsche Bank AG now owns 74,857 shares of the company’s stock worth $1,913,000 after acquiring an additional 17,560 shares in the last quarter. 92.10% of the stock is owned by institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.